Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 07 2022
Historique:
received: 20 02 2022
accepted: 25 07 2022
entrez: 29 7 2022
pubmed: 30 7 2022
medline: 3 8 2022
Statut: epublish

Résumé

The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL) and survival in these patients. A total of 847 stable patients with advanced HFrEF (57.4 ± 11.3 years, 67.7% NYHA III/IV, LVEF 23.6 ± 5.8%) underwent clinical and laboratory evaluation and were prospectively followed for a median of 1126 (IQRs 410; 1781) days for occurrence of death, urgent heart transplantation or mechanical circulatory support implantation. A subgroup of 380 patients (44.9%) had DM, 87 of DM patients (22.9%) were treated with MET. Despite worse insulin sensitivity and more severe DM (higher BMI, HbA1c, worse insulin resistance), MET-treated patients exhibited more stable HF marked by lower BNP level (400 vs. 642 ng/l), better LV and RV function, lower mitral and tricuspid regurgitation severity, were using smaller doses of diuretics (all p < 0.05). Further, they had higher eGFR (69.23 vs. 63.34 ml/min/1.73 m

Identifiants

pubmed: 35906276
doi: 10.1038/s41598-022-17327-4
pii: 10.1038/s41598-022-17327-4
pmc: PMC9338272
doi:

Substances chimiques

Metformin 9100L32L2N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13038

Informations de copyright

© 2022. The Author(s).

Références

Diabetes Care. 1996 Dec;19(12):1449-50
pubmed: 8941483
Trials. 2009 Feb 09;10:12
pubmed: 19203392
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Circulation. 2005 Feb 8;111(5):583-90
pubmed: 15699279
Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002967
pubmed: 20393934
Arch Intern Med. 2010 Nov 22;170(21):1892-9
pubmed: 21098347
BMJ. 2015 Oct 02;351:h4984
pubmed: 26432468
Diabetes Care. 2005 Oct;28(10):2345-51
pubmed: 16186261
Sci Rep. 2021 Jan 8;11(1):137
pubmed: 33420333
Circulation. 2019 Sep 17;140(12):1004-1014
pubmed: 31362530
Am J Cardiol. 2010 Oct 1;106(7):1006-10
pubmed: 20854965
Circulation. 2018 Aug 14;138(7):678-691
pubmed: 29459363
Ann Intern Med. 2017 Feb 07;166(3):191-200
pubmed: 28055049
Circulation. 1997 Jun 17;95(12):2660-7
pubmed: 9193435
Can J Cardiol. 2019 Apr;35(4):462-470
pubmed: 30935637
J Card Fail. 2010 Mar;16(3):200-6
pubmed: 20206893
Circ Heart Fail. 2011 Jan;4(1):53-8
pubmed: 20952583
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Diabetes Care. 2010 Jun;33(6):1213-8
pubmed: 20299488
JACC Heart Fail. 2014 Dec;2(6):573-82
pubmed: 24998080
J Intern Med. 1999 Sep;246(3):299-307
pubmed: 10475998
Eur J Heart Fail. 2016 Mar;18(3):260-6
pubmed: 26751260
Circulation. 2021 Jan 26;143(4):337-349
pubmed: 33175585
Eur Heart J. 2019 Nov 1;40(41):3409-3417
pubmed: 30993313
Circulation. 2019 Apr 30;139(18):2129-2141
pubmed: 30884964
Am J Cardiol. 1993 May 1;71(12):1106-7
pubmed: 8475878
Eur J Echocardiogr. 2006 Mar;7(2):79-108
pubmed: 16458610
Metabolism. 2021 Feb;115:154452
pubmed: 33248064
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
J Am Coll Cardiol. 2019 Apr 23;73(15):1931-1944
pubmed: 30999996
Sci Rep. 2021 Apr 14;11(1):8091
pubmed: 33854147
Int J Cardiol. 2013 Jun 20;166(2):404-12
pubmed: 22112681
J Am Heart Assoc. 2019 Nov 5;8(21):e011640
pubmed: 31630591
Circ Heart Fail. 2019 Apr;12(4):e005418
pubmed: 30922066
Cell Rep. 2018 May 22;23(8):2532
pubmed: 29791861
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Circ Heart Fail. 2013 May;6(3):395-402
pubmed: 23508758
Nat Med. 2017 Jul;23(7):850-858
pubmed: 28530702
Heart Fail Rev. 2021 Nov;26(6):1437-1445
pubmed: 32157481
Diabetes Care. 2005 Jul;28(7):1680-9
pubmed: 15983320
Biochem J. 2000 Jun 15;348 Pt 3:607-14
pubmed: 10839993
Diabetes Care. 2007 Dec;30(12):e129
pubmed: 18042738
Nature. 2020 Feb;578(7795):444-448
pubmed: 31875646
ESC Heart Fail. 2021 Apr;8(2):1417-1426
pubmed: 33512782
Diabetologia. 2010 Dec;53(12):2546-53
pubmed: 20838985
Eur J Heart Fail. 2020 Sep;22(9):1628-1637
pubmed: 31863557
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Sci Rep. 2019 Feb 18;9(1):2218
pubmed: 30778081
Circ Res. 2016 Aug 19;119(5):652-65
pubmed: 27418629
J Biol Chem. 2000 Jan 7;275(1):223-8
pubmed: 10617608

Auteurs

Jan Benes (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic. jan.benes@ikem.cz.

Martin Kotrc (M)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Katerina Kroupova (K)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Peter Wohlfahrt (P)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Jan Kovar (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Janka Franekova (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Marketa Hegarova (M)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Lenka Hoskova (L)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Eva Hoskova (E)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Terezie Pelikanova (T)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Petr Jarolim (P)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Josef Kautzner (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Vojtech Melenovsky (V)

Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Videnska 1958/9, 140 21, Praha 4, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH